StreetInsider.com News Articles

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:

IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.

The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:

The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:

The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:

The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:

The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:

The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:

The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:

The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:

The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:

The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:

The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:

The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:

The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot
In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:

The

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:

IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.

Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET to Sponsor Tech Talks at State of Spine Surgery Think Tank

Thu, 25 Jun 2026 12:05:00 -0400

MEMPHIS, Tenn.--(BUSINESS WIRE)-- IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), an implant company specializing in innovative spinal devices and the distribution of advanced medical equipment, has announced its support and participation at the State of Spine Surgery Think Tank, June 25-27 in San Jose del Cabo, Mexico.
The State of Spine Surgery Think Tank event moves beyond traditional lectures and exhibits to focus on meaningful discussion, practical insights, and real-world challenges facing spine surgeons today.
IMPLANET will be sponsoring two talks at the event:
Safdar Khan, MD, Professor of Orthopaedic Surgery and Vice Chair for